ID

13684

Descripción

Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01456013

Link

https://clinicaltrials.gov/show/NCT01456013

Palabras clave

  1. 28/2/16 28/2/16 -
Subido en

28 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Contrast Induced Nephropathy NCT01456013

Eligibility Contrast Induced Nephropathy NCT01456013

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or non-pregnant female equal or greater than the age of 18 years old and is able to provide informed consent.
Descripción

age; gender; informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0021430
subject is scheduled to undergo an elective catheterization procedure
Descripción

Catheterization elective

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007430
UMLS CUI [1,2]
C0439608
hemodynamically stable
Descripción

hemodynamically stable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0578150
at increased risk of developing cin
Descripción

Contrast Induced Nephropathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0748300
subject has agreed to all follow-up testing.
Descripción

testing follow-up

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0039593
UMLS CUI [1,2]
C1522577
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
class 3 or 4 congestive heart failure (chf)
Descripción

congestive heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018802
is anuric or has undergone renal replacement therapy within the past month, or has a known inability to have a foley catheter placed.
Descripción

renal replacement therapy; foley catheter

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206074
UMLS CUI [2]
C0179804
subject has been hospitalized or treated medically for any change in renal function over the past week (i.e. dialysis, etc.), or a significant change in renal function is noted at time of screening.
Descripción

hospitalization; dialysis; renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019993
UMLS CUI [2]
C0011946
UMLS CUI [3]
C0232804
has documented severe aortic stenosis.(note: subjects who have undergone successful replacement or repair of their aortic valve are not excluded.)
Descripción

severe aortic stenosis; Replacement of aortic valve

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3806272
UMLS CUI [2]
C0003506
currently has a known clinically significant electrolyte imbalance or clinically significant arrhythmias which compromise subject's hemodynamic state.
Descripción

Hemodynamics; electrolyte imbalance; Cardiac Arrhythmia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019010
UMLS CUI [2]
C0342579
UMLS CUI [3]
C0003811
patient has moderate to severe anemia (hematocrit < 27%) at screening
Descripción

severe anemia; Hematocrit level

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0238644
UMLS CUI [2]
C0518014
has received contrast within 10 days of procedure or has a planned additional cardiac or renal or other major surgical procedure within the7 day follow-up period.
Descripción

major surgical procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038894
has ruled in for an serious heart attack within 48 hours of the planned procedure
Descripción

heart attack

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
has documented respiratory insufficiency as evidenced by an oxygen saturation of < 90% on room air assessed on day of procedure.
Descripción

respiratory insufficiency; Oxygen saturation measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0035229
UMLS CUI [2]
C0523807
planned addition, discontinuation or dose adjustment of the nephrotoxic drugs
Descripción

dose adjustment; drug nephrotoxic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826232
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C1514118
subject has a known hypersensitivity to furosemide and/or the contrast agent being used.
Descripción

hypersensitivity furosemide

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0016860
subject is currently, plans, or has been enrolled in another clinical study involving use of an investigational drug or device within the prior 30 days.
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
subject is pregnant or breastfeeding.
Descripción

lactating; pregnant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828358
UMLS CUI [2]
C0549206
subject is unable to provide informed consent.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430

Similar models

Eligibility Contrast Induced Nephropathy NCT01456013

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age; gender; informed consent
Item
male or non-pregnant female equal or greater than the age of 18 years old and is able to provide informed consent.
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0021430 (UMLS CUI [3])
Catheterization elective
Item
subject is scheduled to undergo an elective catheterization procedure
boolean
C0007430 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
hemodynamically stable
Item
hemodynamically stable
boolean
C0578150 (UMLS CUI [1])
Contrast Induced Nephropathy
Item
at increased risk of developing cin
boolean
C0748300 (UMLS CUI [1])
testing follow-up
Item
subject has agreed to all follow-up testing.
boolean
C0039593 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
congestive heart failure
Item
class 3 or 4 congestive heart failure (chf)
boolean
C0018802 (UMLS CUI [1])
renal replacement therapy; foley catheter
Item
is anuric or has undergone renal replacement therapy within the past month, or has a known inability to have a foley catheter placed.
boolean
C0206074 (UMLS CUI [1])
C0179804 (UMLS CUI [2])
hospitalization; dialysis; renal function
Item
subject has been hospitalized or treated medically for any change in renal function over the past week (i.e. dialysis, etc.), or a significant change in renal function is noted at time of screening.
boolean
C0019993 (UMLS CUI [1])
C0011946 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
severe aortic stenosis; Replacement of aortic valve
Item
has documented severe aortic stenosis.(note: subjects who have undergone successful replacement or repair of their aortic valve are not excluded.)
boolean
C3806272 (UMLS CUI [1])
C0003506 (UMLS CUI [2])
Hemodynamics; electrolyte imbalance; Cardiac Arrhythmia
Item
currently has a known clinically significant electrolyte imbalance or clinically significant arrhythmias which compromise subject's hemodynamic state.
boolean
C0019010 (UMLS CUI [1])
C0342579 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
severe anemia; Hematocrit level
Item
patient has moderate to severe anemia (hematocrit < 27%) at screening
boolean
C0238644 (UMLS CUI [1])
C0518014 (UMLS CUI [2])
major surgical procedure
Item
has received contrast within 10 days of procedure or has a planned additional cardiac or renal or other major surgical procedure within the7 day follow-up period.
boolean
C0038894 (UMLS CUI [1])
heart attack
Item
has ruled in for an serious heart attack within 48 hours of the planned procedure
boolean
C0027051 (UMLS CUI [1])
respiratory insufficiency; Oxygen saturation measurement
Item
has documented respiratory insufficiency as evidenced by an oxygen saturation of < 90% on room air assessed on day of procedure.
boolean
C0035229 (UMLS CUI [1])
C0523807 (UMLS CUI [2])
dose adjustment; drug nephrotoxic
Item
planned addition, discontinuation or dose adjustment of the nephrotoxic drugs
boolean
C2826232 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C1514118 (UMLS CUI [2,2])
hypersensitivity furosemide
Item
subject has a known hypersensitivity to furosemide and/or the contrast agent being used.
boolean
C0020517 (UMLS CUI [1,1])
C0016860 (UMLS CUI [1,2])
Study Subject Participation Status
Item
subject is currently, plans, or has been enrolled in another clinical study involving use of an investigational drug or device within the prior 30 days.
boolean
C2348568 (UMLS CUI [1])
lactating; pregnant
Item
subject is pregnant or breastfeeding.
boolean
C2828358 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
informed consent
Item
subject is unable to provide informed consent.
boolean
C0021430 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial